Evidence map›Paper›PMID 39710373›Full record

ArticleMicrobes and environments2024

Evaluation of Soil Antagonism against the White Root Rot Fungus Rosellinia necatrix and Pathogen Mycosphere Communities in Biochar-amended Soil.

Yong Guo, Sachie Horii, Satoko Kanematsu

Abstract read
In one paragraph

Article in Microbes and environments, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yong GuoInstitute for Plant Protection, National Agriculture and Food Research Organization (NARO).
Sachie HoriiInstiture of Fruit Tree and Tea Science, National Agriculture and Food Research Organization (NARO).
Satoko KanematsuInstitute for Plant Protection, National Agriculture and Food Research Organization (NARO).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

White root rot disease caused by Rosellinia necatrix is a growing issue in orchards, and biochar pyrolyzed from the pruned branch residues of fruit trees has potential as a soil amendment agent with a number of benefits, such as long-term carbon sequestration. However, the effects of pruned branch biochar on white root rot disease remain unclear. Therefore, we compared direct antagonism against R. necatrix between soils with and without pruned pear branch biochar using a toothpick method and then linked soil physicochemical properties and microbial communities with soil antagonism. The results obtained showed that soil antagonism against the pathogen, that is, the extinction zone of R. necatrix in mycelial toothpicks, decreased in soils amended with 20% (v/v) pruned branch biochar. Soil pH was neutralized and aeration was promoted by the biochar amendment, which may be favorable for pathogen growth. An investigation of microbial communities surrounding R. necatrix mycelia indicated that antagonistic fungi affiliated with Chaetomiaceae and Trichoderma were selectively excluded from the mycosphere community in biochar-amended soil. Therefore, the enrichment of these indigenous antagonistic fungi may be important for controlling R. necatrix. Based on the present results, we do not recommend the application of pruned branch biochar to the soil area associated with the roots of fruit trees in order to avoid increasing the risk of white root rot in orchards.

Indexed as

CharcoalPlant DiseasesSoilSoil MicrobiologyAntibiosisMyceliumPlant RootsPyrusbiocharCharcoalSoilJapanese pear orchardmycosphere microbiomepruned branch biocharRosellinia necatrixsoil antagonism

Identifiers

PMID39710373
PMCPMC11821764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.